TELO
Telomir Pharmaceuticals, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Telomir Pharmaceuticals (TELO) Stock: Buy, Sell, or Hold?
$0.50
-0.09 (-15.90%)
▼
5d:
-35.85%
30d:
-52.34%
90d:
-54.09%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
38/100
Position
OVERSOLD
30-Day Fair Range
$0.77 – $1.14
Position: OVERSOLD
Forward P/E & Valuation
-4.6x
Next 12M consensus est.
Wall Street Target
$4.00
+699.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.47 / $0.99
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: TELO is down 35.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When TELO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TELO is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.77 to $1.14.
Technical Outlook: Technically, TELO is in a downtrend. Immediate support is located at $0.47, while resistance sits at $0.99. Short-term momentum is weak, with the stock down 15.9% recently.
Market Sentiment: TELO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+699.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TELO is in a downtrend. Immediate support is located at $0.47, while resistance sits at $0.99. Short-term momentum is weak, with the stock down 15.9% recently.
Market Sentiment: TELO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+699.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.77 -
$1.14
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$0.77 -
$1.14
Current vs Trading Range
OVERSOLD
Support Level
$0.47
Resistance Level
$0.99
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-15.9%)
- BULLISH: Trading 699.4% below Wall St target ($4.00)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-4.55
Wall Street Target
$4.00
(+699.4%)
Share TELO Analysis
Share this live TELO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TELO)
Bullish
3 Retail Mentions
Reddit / WSB Comments
2
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 7, 2026
Daily AI digest
AI Retail Discussion Summary:
Billionaire entrepreneur John Paul DeJoria increases investment in Telomir Pharmaceuticals, raising approximately $5.6 million through a PIPE financing. DeJoria, who previously owned 5.0% of Telomir's outstanding common stock, further boosts his stake as the company advances its lead program, Telomir-Zn, into clinical development.
Key Retail Themes:
Company financing
Clinical trial advancement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 10:07 PM ET
Data refreshes hourly during market hours. Next update: 11:07 PM
Data refreshes hourly during market hours. Next update: 11:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TELO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 36 SELL |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 64 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TELO Research Pages
